Outlook Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 9 5 3 4 3 8 0 0 0 0 0
Przychód Δ r/r 0.0% -42.3% -42.9% 27.9% -19.0% 163.8% -100.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 99.7% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -12 -47 -52 -36 -25 -36 -37 -52 -63 -53 -72
EBIT Δ r/r 0.0% 275.7% 11.2% -30.7% -29.1% 42.7% 1.5% 40.4% 21.9% -15.8% 35.0%
EBIT (%) -136.9% -892.1% -1737.1% -941.4% -824.1% -445.6% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 1 2 1 6 4 3 2 1 1 2 0
EBITDA (mln) -12 -45 -49 -33 -22 -22 -36 -52 -63 -53 -72
EBITDA(%) -127.2% -857.2% -1656.7% -870.7% -725.2% -266.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 -0 0 1 -4 -3 -3 0 0 0 0
Zysk Netto (mln) -14 -47 -53 -39 -46 -35 -35 -53 -66 -59 -75
Zysk netto Δ r/r 0.0% 245.1% 12.5% -27.2% 18.7% -25.1% 2.1% 50.9% 24.2% -10.7% 27.8%
Zysk netto (%) -151.7% -908.1% -1789.8% -1019.3% -1493.6% -423.8% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -7.77 -25.22 -24.79 -12.94 -2.53 -1.9 -9.71 -6.96 -6.23 -4.72 -9.84
EPS (rozwodnione) -7.77 -25.22 -24.79 -12.93 -2.53 -1.9 -9.71 -6.96 -6.23 -4.72 -9.76
Ilośc akcji (mln) 2 2 2 3 18 18 4 8 11 13 19
Ważona ilośc akcji (mln) 2 2 2 3 18 18 4 8 11 13 19
Waluta USD USD USD USD USD USD USD USD USD USD USD